文献速递肝胆胰外科

微创中央区肝切除术治疗中央型肝脏病变的病例系列

Minimally invasive mesohepatectomy for centrally located liver lesions-a case series.
PubMed 文献 · Surg Endosc · 2022-06-06

中位手术时间393分钟,中位出血量550 ml,1例中转开腹,1例发生III级并发症,中位住院7天,术后90天内无再入院。结论认为该术式在经选择的良恶性肝脏病变患者中可行且安全。

要点

  • 微创中央区肝切除术在经选择的患者中可行且安全
  • 1例发生III级并发症,无90天内再入院

核心结论

  • 微创中央区肝切除术在经选择的良恶性肝脏病变患者中是可行且安全的。

主要发现

  • 中位手术时间393分钟(IQR 298-573分钟),中位总出血量550 ml(IQR 413-850 ml),1例中转开腹。
  • 中位病灶大小60 mm,所有病例最终病理切缘阴性;1例发生III级并发症。
  • 中位住院时间7天(IQR 5-12天),功能恢复中位时间2天(IQR 1-4天),术后90天内无再入院。

临床怎么用

  • 对于经选择的中央型肝脏良恶性病变,可考虑采用微创解剖性中央区肝切除术(Glissonean蒂入路)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Resection of centrally located liver lesions remains a technically demanding procedure. To date, there are limited data on the effectiveness and safety of minimally invasive mesohepatectomy for benign and malignant lesions. It was therefore the objective of this study to evaluate the perioperative outcomes of minimally invasive mesohepatectomy for liver tumors at a tertiary care hospital. METHODS: Consecutive patients who underwent a minimally invasive anatomic mesohepatectomy using a Glissonean pedicle approach from April 2018 to November 2021 were identified from a prospective database. Demographics, operative details, and postoperative outcomes were analyzed using descriptive statistics for continuous and categorical variables. RESULTS: A total of ten patients were included, of whom five patients had hepatocellular carcinoma, one patient had cholangiocarcinoma, three patients had colorectal liver metastases, and one patient had a hydatid cyst. Two and eight patients underwent robotic-assisted and laparoscopic resections, respectively. The median operative time was 393 min (interquartile range (IQR) 298-573 min). Conversion to laparotomy was required in one case. The median lesion size was 60 mm and all cases had negative resection margins on final histopathological analysis. The median total blood loss was 550 ml (IQR 413-850 ml). One patient had a grade III complication. The median length of stay was 7 days (IQR 5-12 days). Time-to-functional recovery was achieved after a median of 2 days (IQR 1-4 days). There were no readmissions within 90 days after surgery. CONCLUSION: Minimally invasive mesohepatectomy is a feasible and safe approach in selected patients with benign and malignant liver lesions.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Birgin E, Hartwig V, Rasbach E, et al. Minimally invasive mesohepatectomy for centrally located liver lesions-a case series. Surg Endosc. 2022. PMID: 35668311. doi:10.1007/s00464-022-09342-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。